Novel association of a familial TGFBR1 mutation in Loeys-Dietz syndrome with concomitant hematologic malignancy by Disha, Kushtrim et al.
ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online)
− 376 −
Received: March 12, 2019, Revised: August 6, 2019, Accepted: August 28, 2019, Published online: October 5, 2019
Corresponding author: Kushtrim Disha, Department of Cardiac Surgery, Central Hospital Bad Berka, Robert-Koch-Allee 9, 99437 Bad 
Berka, Germany
(Tel) 49-36458541134 (Fax) 49-3645853510 (E-mail) k_disha@hotmail.com
© The Korean Society for Thoracic and Cardiovascular Surgery. 2019. All right reserved.
 This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ 
licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Novel Association of a Familial TGFBR1 Mutation 
in Loeys-Dietz Syndrome with Concomitant 
Hematologic Malignancy
Kushtrim Disha, M.D., M.P.H.1, Solveig Schulz, M.D.2, Martin Breuer, M.D.1, 
Tamer Owais, M.D., Ph.D.1, Evaldas Girdauskas, M.D., Ph.D.3, Thomas Kuntze, M.D.1
1Department of Cardiac Surgery, Central Hospital Bad Berka, Bad Berka; 2Center of Human Genetics and 
Anthropology, Jena University Hospital, Jena; 3Department of Cardiovascular Surgery, 
University Heart Center Hamburg, Hamburg, Germany
Concomitant Loeys-Dietz syndrome (LDS) and hematologic malignancies are exceptionally rare. This is the first report of a patient operated on for aortic root dilation who had been previously diagnosed with LDS and B-cell-lymphoma. After completion of chemotherapy and complete remission, an elective valve-sparing aortic root replacement (using the David-V method) was performed. Due to the positive family history, pre-operative genetic counseling was conducted, and revealed LDS with a TGFBR1 (transforming growth factor beta receptor type I) mutation in 6 probands of the family, albeit in 1 of them posthumously. This missense mutation has been previously described in relation to aortic dissection, but a causative relationship to malig-nancy has so far neither been proposed nor proven.
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Case reportA 54-year-old man was referred to our clinic to undergo elective surgery for an aortic root dilation measuring 54 mm in diameter (Fig. 1A). Routine echocardiography had been performed as a screening examination due to newly diagnosed sleep apnea/hy-popnea syndrome 6 months previously and revealed aortic root dilation with a concomitant mild aortic regurgitation. The diagnosis was confirmed by means of a subsequent aortic computed tomography (CT) scan. The otherwise asymptomatic patient revealed a positive familial history of 2 female second-degree 
cousins. Both cousins had been previously diagnosed with Loeys-Dietz syndrome (LDS) with a hetero-zygous missense mutation, c.759G＞A, p.(Met253Ile), in exon 4 of the transforming growth factor beta re-ceptor type I (TGFBR1) gene. Unfortunately, the first cousin was diagnosed only postmortem after passing away from a ruptured aortic root aneurysm at the age of 30, just hours after giving birth to triplets. The other cousin (sister of the deceased) underwent genetic counseling, which revealed exactly the same mutation as well as clinical signs of arachnodactyly, dolichocephaly, scoliosis, and hypermobility, thus es-tablishing the diagnosis of LDS. Furthermore, the 
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Fig. 1. Preoperative multi-slice 
computed tomographic scan of the 
chest showing: (A) the dilated aort-
ic root and (B) pronounced left-ax-
illar lymphadenopathy with con-
glomerates of lymph nodes measur-
ing up to 33 mm (white arrow).
triplets of the deceased sister were subsequently screened and 2 of them were detected to have the same missense mutation and various concomitant clinical manifestations, ranging from general hyper-mobility, hypermobile fingers, and arachnodactyly to mild cerebral palsy in 1 of them. Targeted genetic counseling of our patient also revealed the above-mentioned mutation in the TGFBR1 gene, as well as mild scoliosis, dolichocephaly, and arachnodactyly. Therefore, LDS type 1 was diagnosed. Moreover, one of the patient’s offspring (a 25-year-old son) also tested positive for the same mutation. Noteworthy, all probands were negative for FBN1 gene mutations.Prior to the writing of this case report, the patient was verbally informed and he declared his willing-ness for his case to be published.While on the waiting list for elective surgery of the aortic root, the patient presented to the emer-gency unit of our hospital with an unclear swelling of the left axilla and left arm. Consecutive CT imag-ing of the chest revealed a pronounced left axillar and infraclavicular lymphadenopathy, with conglom-erates of lymph nodes measuring up to 33 mm (Fig. 1B). Lymph node biopsy revealed diffuse large-cell B-cell lymphoma in stage IIA (according to the Ann Arbor staging classification, aaIPI [low risk]). A pre-phase treatment with vincristine/prednisolone and 1 course of the R-CHOP protocol (rituximab, doxorubicin, mesna, cyclophosphamide, vincristine, and pegfilgrastim) were initiated. After receiving a total of 6 courses of the R-CHOP protocol within 5 months, complete clinical and imaging remission was established.Two months after completing the R-CHOP protocol, an elective aortic root operation was performed, us-
ing a standard median sternotomy approach. Inspec-tion of the aortic root showed symmetrical root dila-tion combined with a significant thinning of the aort-ic wall tissue. The aortic valve consisted of 3 cusps without signs of calcific degeneration or any other structural deterioration. Valve-sparing aortic root re-placement (using the David-V method) was con-ducted with subsequent reimplantation of both coro-nary ostia. Intraoperative transesophageal echo-cardiography showed a competent aortic valve. The entire postoperative course was uneventful and the patient was discharged on postoperative day 9.The postoperative management of the patient in-cluded β-blockers and an angiotensin-receptor an-tagonist (losartan). The latter category of medications is beneficial due to their effects on the TGF-β sig-naling cascade. Moreover, exercise restrictions to re-duce stress on the aortic and arterial tissue included avoidance of competitive sports and isometric exercises.
DiscussionSince its first description, LDS has been the subject of intense research due to its deleterious car-diovascular manifestations, such as aortic dissection and cerebral hemorrhage [1,2]. It may present with diverse craniofacial, skeletal, cardiovascular, and cuta-neous clinical features [1]. The majority of LDS pa-tients die of aortic dissection and cerebral hemor-rhage, at a very early mean age of 26 years [1]. However, the survival of affected individuals can be improved by early detection, surveillance, and early treatment [3]. Since LDS represents a rather new genotypic and phenotypic entity, the spectrum of concomitant multisystemic manifestations is still a 
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Fig. 2. Pedigree of a family with Loeys-Dietz syndrome associated 
with c.759G＞A p.(Met253Ile) in the TGFBR1 gene. The index pa-
tient is indicated by an arrow. n.a., no DNA available; Wt, wild 
type (no mutation detected); TGFBR1, transforming growth fac-
tor beta receptor type I.
topic of research. Furthermore, to date, little is known about potential associations of LDS with malignancies.Transforming growth factor-beta receptor I and II (TGFBR1 and TGFBR2) mutations were the first ge-netic abnormalities diagnosed in LDS, which were later expanded to include other genes, such as 
SMAD3 and TGFB2, which were also found to cause LDS [3]. However, significant phenotypic variability within and between individuals affected 4 LDS have been reported [3]. Due to the multisystemic manifes-tations of LDS, along with its aggressive clinical course and the need for intense life-long surveillance, an interdisciplinary team approach is strongly recom-mended in the care of these patients. Moreover, aort-ic dimensions alone are not a good predictor of ad-verse aortic events in LDS patients, as aortic dis-section has been reported to occur in aortas with a diameter of less than 4.0 cm [1]. This is quite differ-ent from patients presenting with Marfan syndrome, in whom aortic risk increases significantly as aortic root dimensions exceed 5.0 cm. Surgical correction by means of valve-sparing root surgery is a very rea-sonable treatment option for LDS patients, which dis-tinguishes LDS patients from those presenting with vascular Ehlers-Danlos syndrome, who are prone to fatal perioperative complications [4]. Although there are many overlapping features between patients with Marfan syndrome and those with LDS, patients with LDS most often present with cardiovascular features first, while this is not the case for Marfan syndrome.The concomitant occurrence of LDS and malig-nancy is a very rare manifestation, and no systematic data exist regarding such an association. Reports of concomitant LDS and hematologic malignancies are exceptionally rare, which furthermore hinders the possibility of establishing a causative relationship be-tween both phenomena. To the best of our knowl-edge, this is the first report of a clinically apparent association between LDS and B-cell lymphoma. Furthermore, this particular mutation has been pre-viously found in a family with several individuals af-fected by aortic dissection [5], but the possibility of a causative relationship with malignancies has not yet been established. Although the life-long risk of malig-nancy in LDS patients has not been well established, TGF-β signaling has been proposed to play a role in the initial stage of oncogenesis, as well as in the lat-
er stages, by promoting tumor progression and meta-stasis formation [6]. Our patient was diagnosed with a heterozygous missense mutation, c.759G＞A, p.(Met253Ile) in exon 4 of the TGFBR1 gene. This se-quence alteration in exon 4 (from G to A at codon 759) resulted in the amino acid methionine being re-placed with isoleucine (i.e., p.(Met253Ile)). Consequently, a highly conserved hydrophobic amino acid was replaced by one with similar physical and chemical properties. This, in turn, may have con-tributed to destabilization of the protein structure, with potential impairment of TGFBR1 function that would interfere with the TGF-β pathway. Hematologic malignancies, especially B-cell lympho-ma, have received relatively little attention regarding TGF-β signaling. It was reported that B-cell lympho-ma cell lines displayed less sensitivity to TGF-β than primary B cells. This has important implications for the development of B-cell lymphoma, as it indicates a loss of sensitivity towards the growth-inhibitory ef-fects of TGF-β [7]. Furthermore, a meta- analysis found that certain polymorphisms of TGFBR1 were associated with an increased risk of carcinogenesis [8]. To what extent TGFBR1 mutations in patients with LDS contribute to oncogenesis remains in-completely elucidated. At present, no specific cancer pattern has emerged, and it remains unknown whether patients with LDS are at an increased risk of developing malignancies [3]. Therefore, thorough interdisciplinary clinical and basic research is needed in order to fully clarify the risk of oncogenesis in pa-tients with LDS. Our patient was the oldest repre-
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sentative of all known family members with this mu-tation, which in part may explain the singular occur-rence of such a malignancy in the analyzed family. Six family members who were tested for this muta-tion were diagnosed positive (Fig. 2). Considering the high penetrance and the variable expression of the genetic defect in this family, along with the docu-mented aggressive clinical course of LDS and the ex-cellent long-term results of valve-sparing root sur-gery, increased alertness and timely aortic root inter-vention should be strongly considered in patients who test positive for this TGFBR1 mutation.
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